SecBot SecBot
144 ·Filed Aug 31, 2026

JAZZ

Jazz Pharmaceuticals plc
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago SEC0001188919-26-000013
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

Routine insider sale for tax/compensation purposes following RSU vesting. No trading signal. Monitor for any larger or unexpected insider sales by executives or significant holders.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
JAZZ ▼ -5.00% at T+20d
NEUTRAL call -5.00% · α vs SPY -5.32% · entry $243.71 → $231.52
Next anchor: T+60d in 29d
Latest observation: T+37 -13.58% FF3 residual α
Entry = T+0 close
Aug 31, 2026
via day close
T+1d
+0.76%
call +0.76% · α +0.32%
$245.57
settled 8w ago
T+5d
-0.98%
call -0.98% · α -1.07%
$241.31
settled 7w ago
T+20d
-5.00%
call -5.00% · α -5.32%
$231.52
settled 27d ago
T+60d
Pending
in 29d

Price Chart

Loading chart...

Executive Summary

Director Ted W. Love filed a Form 144 notice of intent to sell 1,527 shares of Jazz Pharmaceuticals common stock, valued at approximately $373,413. The shares were acquired via restricted stock vesting on August 28, 2026, and the sale appears to be a routine compensation-related transaction. The small size relative to market cap and the director-level status make this a non-material event.

Key Facts

  • Ted W. Love, a Director of Jazz Pharmaceuticals, filed Form 144 to sell 1,527 shares.
  • Shares were acquired on 08/28/2026 via restricted stock vesting (compensation).
  • Estimated sale value: $373,413 based on filing date.
  • Sale intended to be executed through E*TRADE on or about 08/31/2026.

Financial Impact

Negligible — 1,527 shares represent ~0.0023% of Jazz's $15.9B market cap.

dilution

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (26 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001188919-26-000013
Document: 0001188919-26-000013-index.html0001188919-26-000013
Document: 0001188919-26-000013.txt0001188919-26-000013
28 reports for JAZZ
Performance horizon
60% Hit rate @ T+1 3 of 5 directional calls Went positive at some point 4 of 5 best @ T+60▲ +22.04%Feb 24, 2026
Filters
Rows
Reports for JAZZ — sortable, filterable
TypeNow
Oct 19, 2026
6d ago
Press Release
NEUTRAL ★ 1/10
$213.76 $211.97▼ −0.84%▼ −1.36%$210.99 (−1.30%)
Oct 9, 2026
17d ago
8-K
NEUTRAL ★ 2/10
$218.42 $216.75▼ −0.76%▼ −0.70%$210.99 (−3.40%)
Oct 8, 2026
17d ago
144
NEUTRAL ★ 2/10
$218.42 $216.75▼ −0.76%▼ −0.70%$210.99 (−3.40%)
Oct 6, 2026
19d ago
144
NEUTRAL ★ 2/10
$231.19 $222.45▼ −3.78%▼ −3.36%$210.99 (−8.74%)
Oct 1, 2026
24d ago
144
NEUTRAL ★ 2/10
$235.67 $236.04▲ +0.16%▼ −0.52%$210.99 (−10.47%)
Sep 15, 2026
5w ago
8-K
BULLISH ★ 6/10
$240.83 $243.59▲ +1.15%▲ +1.59%$210.99 (−12.39%)
Sep 14, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$240.83 $243.59▲ +1.15%▲ +1.59%$210.99 (−12.39%)
Sep 10, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$245.80 $245.87▲ +0.03%▲ +0.47%$210.99 (−14.16%)
Sep 2, 2026
7w ago
Insider Cluster
BEARISH ★ 4/10
$247.57 $246.81▲ +0.30%▼ −0.08%$210.99 (+14.78%)
Aug 31, 2026
7w ago
144
NEUTRAL ★ 2/10
$243.71 $245.57▲ +0.76%▲ +0.32%$210.99 (−13.43%)
Showing 10 of 28

US Market Status

Market Open — Closes in 5h 16m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 31, 2026